Title: THE GLOBAL PLAN TO STOP TB,
1- THE GLOBAL PLAN TO STOP TB,
- 2006-2015
- Giorgio Roscigno
- Foundation for Innovative New Diagnostics (FIND)
- on behalf of the Stop TB Partnership
- Joint Meeting of the DOTS Expansion, TB/HIV and
DOTS-Plus Working Groups - 15 October, 2005
- Paris
2Presentation on Global Plan to Stop TB
- Outline of presentation on the Global Plan
- what is the Global Plan?
- why do we need a Global Plan?
- the process of developing the Plan
- regional scenarios and Working Group plans
- expected impact
- next steps
3The Global Plan
- the Stop TB Partnership's plan for TB control
over the decade 2006-2015, in working towards the
goal to eliminate TB as a global public health
problem by 2050 - a convincing argument for the resources needed
for action, underpinned by rigorous
epidemiological analysis with robust budget
justifications
4The Global Plan (contd.)
- What activities are necessary (aimed towards
reaching the Stop TB Partnership's targets for
2015)? - At what cost?
- With what impact (implementation WGs)?
5Why do we need a Global Plan to Stop TB?
- As a vision of what we can achieveAs a roadmap
to achieve targetsAs a tool for advocacy and
fundraisingTo support long-term national
planningTo stimulate research and development
6MDG 6 target 8
- "to have halted by 2015, and begun to reverse the
incidence" of TB
7The Stop TB Partnership's targets
- by 2005
- at least 70 of people with infectious TB will
be diagnosed (i.e. under the DOTS strategy) and
at least 85 cured - by 2015
- the global burden of TB disease (prevalence and
deaths) will be reduced by 50 relative to 1990
levels (specifically, this means reducing
prevalence to 155 per 100,000 and deaths to 14
per 100,000 per year by 2015) - by 2050
- the global incidence of TB disease will be less
than 1 case per million population
8WHO-recommended Stop TB Strategy
- 1. Pursuing quality DOTS expansion and
enhancement - Political commitment
- Case detection through bacteriology
- Standardised treatment, with supervision and
patient support - Effective drug supply system
- Monitoring system and impact evaluation
- Additional components
- 2. Addressing TB/HIV and MDR-TB
- 3. Contributing to health system strengthening
- 4. Engaging all care providers
- 5. Empowering patients and communities
- 6. Enabling and promoting research
9Process for developing the Global Plan to Stop TB
- Process is
- coordinated by Stop TB Partnership secretariat
- informed by feedback from first Global Plan
- guided by the Steering Committee
- driven by need to achieve 2015 targets in each
region - dependent on contributions of the 7 Stop TB
Partnership Working Groups (DOTS Expansion
DOTS-Plus TB/HIV drugs diagnostics vaccines
and advocacy, communications social
mobilisation) and of the Secretariat - based on developing projections of the expected
impact and costs of interventions needed to
achieve 2015 targets (for implementation Working
Groups)
10Global Plan has two key dimensions
- Strategic plans of Working Groups and of
Secretariat - Regional scenarios
11Benefits for each WG of development of strategic
plan
- Process
- engages stakeholders
- clarifies activities in line with strategic
direction - aids prioritisation
- identifies resource needs
- Product
- sets out activities (with timelines) linked to
targets - enables monitoring of progress towards goal
- helps resource mobilisation
12Nine epidemiological regions of the world
AFR high HIV
AFR low HIV
Central Europe
Eastern Europe
Established Market Economy
EMR
LAC
SEAR
WPR
13Global Plan regional scenarios
- Regional scenarios
- Impact and costs of implementation of activities
- DOTS
- DOTS-plus
- TB-HIV
14Development of regional scenarios
- Step 1. Defining and costing intervention
packages -
- Step 2. Estimating the magnitude and pace of
scaling up of activities - Step 3. Estimating TB control outcomes and impact
- Step 4. Estimating the cost of DOTS expansion,
DOTS-Plus, TB/HIV and diagnostics
15(No Transcript)
16(No Transcript)
17Summary of planned achievements of R D WGs
18(No Transcript)
19(No Transcript)
20(No Transcript)
21Summary of main messages (1)
- Implementation of the new Stop TB Strategy will
expand equitable access for all to quality TB
diagnosis and treatment. - Over the ten years of this Plan, about 50 million
people will be treated for TB under the Global
Strategy to Stop TB, including about 800,000
MDR-TB patients, and about 3 million TB/HIV
patients will be enrolled on ART. - Some 14 million lives will be saved from
2006-2015. - The first new TB drug for 40 years will be
introduced in 2010, with a new short TB regimen
(1-2 months) shortly after. - By 2010 "point of care" diagnostics will enable
rapid, sensitive and inexpensive detection of
active TB. By 2012, a diagnostic toolbox will
accurately identify people with latent TB
infection and those at high risk of progression
to disease.
22Summary of main messages (2)
- Full funding (US 55 billion) for implementation
of the Plan would result in achievement of - the MDG "to have halted by 2015, and begun to
reverse the incidence" of TB - the Partnerships 2015 targets to halve
prevalence and death rates from a 1990 baseline
globally, with enormous progress in all regions - the 2015 targets most likely later than 2015 in
- E Europe and even later in Africa
23Conclusion together let's Stop TB!
- Next steps
- 1. Global Plan launch at the World Economic Forum
at Davos, 29 January 2006 - 2. Use the Global Plan
- a) to mobilise funds
- to continue current levels of funding
- to fill the US 35 billion funding gap
- (depends on the commitment of national
governments and all those who fund TB control,
and on fulfilling this commitment) - b) to inform the development of regional plans to
Stop TB - c) to assess progress in implementation of the WG
and secretariat strategic plans - 3. Measure impact